Suchergebnisse - "Jain, Michael D"

PubPharm (87)

1

Applying the EHA/EBMT grading for ICAHT after CAR-T : comparative incidence and association with infections and mortality

enthalten in: Blood advances | 2024

von Rejeski, K. | Wang, Y. | Hansen, D. | +14

2

Mismatched donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations

enthalten in: American journal of hematology | 2024

von Caprice, T. | Fan, W. | Kim, J. | +14

3

Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy

enthalten in: Transplantation and cellular therapy | 2024

von Akhtar, O. | Modi, K. | Kim, J. | +18

4

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

enthalten in: Blood cancer discovery | 2024

von Faramand, R. | Lee, S. | Jain, M. | +30

5

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma : results from the US Lymphoma CAR-T Consortium

enthalten in: Blood advances | 2024

von Jain, M. | Jacobs, M. | Gao, F. | +23

CommentIn: Blood Adv. 2024 Feb 27;8(4):1051-1052. - PMID 38411993

6

Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease

enthalten in: bioRxiv.org | 2023

von Khaled, M. | Ren, Y. | Kundalia, R. | +19

7

Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease

enthalten in: bioRxiv : the preprint server for biology | 2023

von Khaled, M. | Ren, Y. | Kundalia, R. | +19

8

The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American journal of hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

9

CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation : A Safe and Feasible Therapy for an Orphan Disease

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Ibrahim, U. | Bassil, C. | Chavez, J. | +5

10

Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma : Phase 1 Results from ZUMA-11

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Jain, M. | Miklos, D. | Jacobson, C. | +14

1
2
3
4
5
6
7
8
9
Nächster »
[9]